Profil
Huib Ovaa is the founder of UbiQ Bio BV, which was founded in 2010.
He was previously the Head of Research at Het Nederlands Kanker Instituut-Antoni van Leeuwenhoek Ziekenh and a Faculty member at Harvard Medical School.
Dr. Ovaa received his doctorate degree from the University of Leiden in 2001.
Anciens postes connus de Huib Ovaa
| Sociétés | Poste | Fin |
|---|---|---|
Harvard Medical School
Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Het Nederlands Kanker Instituut-Antoni van Leeuwenhoek Ziekenh
Het Nederlands Kanker Instituut-Antoni van Leeuwenhoek Ziekenh Investment Trusts/Mutual FundsMiscellaneous Functions as a foundation or endowment | Directeur Technique/Scientifique/R&D | - |
UbiQ Bio BV
UbiQ Bio BV Pharmaceuticals: MajorHealth Technology Specializes in the ubiquitin related reagents, peptides and assays | Fondateur | - |
Formation de Huib Ovaa
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
University of Leiden
University of Leiden Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Het Nederlands Kanker Instituut-Antoni van Leeuwenhoek Ziekenh
Het Nederlands Kanker Instituut-Antoni van Leeuwenhoek Ziekenh Investment Trusts/Mutual FundsMiscellaneous Functions as a foundation or endowment | Miscellaneous |
Harvard Medical School
Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
UbiQ Bio BV
UbiQ Bio BV Pharmaceuticals: MajorHealth Technology Specializes in the ubiquitin related reagents, peptides and assays | Health Technology |
















